Percentage of long-stay residents with at least one day of mood stabiliser supply

Number of long-stay residents who had at least one day of mood stabiliser supply

Number of long-stay residents

Schizophrenia, Tourette's syndrome, and Huntington's disease

Data collected as part of Minimum Data Set (MDS) which is the federally mandated process for clinical assessment of all residents in Medicare and Medicaid certified nursing homes. This process provides a comprehensive assessment of each resident's functional capabilities and helps nursing home staff identify health problems. MDS assessments are completed for all residents in certified nursing homes, regardless of source of payment for the individual resident. MDS assessments are required for residents on admission to the nursing facility, periodically, and on discharge. All assessments are completed within specific guidelines and time-frames. In most cases, participants in the assessment process are licensed health care professionals employed by the nursing home. MDS information is transmitted electronically by nursing homes to the national MDS database at CMS.

Gerlach, L. B., Kales, H. C., Kim, H. M., Bynum, J. P. W., Chiang, C., Strominger, J., & Maust, D. T. (2020). Trends in Antipsychotic and Mood Stabilizer Prescribing in Long-Term Care in the U.S.: 2011-2014. Journal of the American Medical Directors Association, 21(11), 1629-1635